• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾转移性癌

Translocation carcinomas of the kidney.

作者信息

Argani Pedram, Ladanyi Marc

机构信息

Department of Surgical Pathology, The Johns Hopkins Hospital, Baltimore, MD 21231-2410, USA.

出版信息

Clin Lab Med. 2005 Jun;25(2):363-78. doi: 10.1016/j.cll.2005.01.008.

DOI:10.1016/j.cll.2005.01.008
PMID:15848741
Abstract

A significant proportion of RCCs of children and young adults bear specific chromosome translocations that result in gene fusions that involve members of the MiTF/TFE transcription factor family. These include the Xp11-translocation carcinomas, which bear TFE3 gene fusions, and the renal carcinomas with the t(6;11)(p21;q12), which bear an Alpha-TFEB gene fusion. Both types of translocation result in overexpression of the fusion gene products, such that nuclear labeling for TFE3 or TFEB by immunohistochemistry is a sensitive and specific marker of these respective tumor types. The clinical behavior of these neoplasms relative to conventional, adult-type renal carcinomas remains to be determined, and will be an important area of future investigation.

摘要

相当一部分儿童和年轻成人的肾细胞癌存在特定的染色体易位,这些易位导致基因融合,涉及MiTF/TFE转录因子家族成员。其中包括携带TFE3基因融合的Xp11易位癌,以及携带α-TFEB基因融合的t(6;11)(p21;q12)肾癌。这两种易位均导致融合基因产物的过表达,因此通过免疫组织化学对TFE3或TFEB进行核标记是这些相应肿瘤类型的敏感且特异的标志物。相对于传统的成人型肾癌,这些肿瘤的临床行为仍有待确定,并且将是未来研究的一个重要领域。

相似文献

1
Translocation carcinomas of the kidney.肾转移性癌
Clin Lab Med. 2005 Jun;25(2):363-78. doi: 10.1016/j.cll.2005.01.008.
2
Cathepsin-K immunoreactivity distinguishes MiTF/TFE family renal translocation carcinomas from other renal carcinomas.组织蛋白酶K免疫反应性可将MiTF/TFE家族肾易位癌与其他肾癌区分开来。
Mod Pathol. 2009 Aug;22(8):1016-22. doi: 10.1038/modpathol.2009.58. Epub 2009 Apr 24.
3
Pediatric renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions and clinicopathologic associations.与Xp11.2易位/TFE3基因融合相关的小儿肾癌及其临床病理关联
Pediatr Dev Pathol. 2005 Mar-Apr;8(2):168-80. doi: 10.1007/s10024-004-9106-3. Epub 2005 Mar 8.
4
Overexpression of cyclin D1, D3, and p21 in an infantile renal carcinoma with Xp11.2 TFE3-gene fusion.伴有Xp11.2 TFE3基因融合的婴儿肾癌中细胞周期蛋白D1、D3和p21的过表达
Pathol Res Pract. 2008;204(8):589-97. doi: 10.1016/j.prp.2008.01.010. Epub 2008 Mar 20.
5
Molecular mechanisms underlying the MiT translocation subgroup of renal cell carcinomas.肾细胞癌MiT易位亚组的分子机制
Cytogenet Genome Res. 2007;118(2-4):157-65. doi: 10.1159/000108296.
6
Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum.成人Xp11易位性肾细胞癌:临床、病理及基因谱的扩展
Am J Surg Pathol. 2007 Aug;31(8):1149-60. doi: 10.1097/PAS.0b013e318031ffff.
7
Renal carcinomas with the t(6;11)(p21;q12): clinicopathologic features and demonstration of the specific alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCR.伴有t(6;11)(p21;q12)的肾癌:临床病理特征及通过免疫组织化学、逆转录聚合酶链反应和DNA聚合酶链反应对特定α-TFEB基因融合的证实
Am J Surg Pathol. 2005 Feb;29(2):230-40. doi: 10.1097/01.pas.0000146007.54092.37.
8
Adult-onset renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusion with smooth muscle stroma and abnormal vessels.成人发病的肾细胞癌与Xp11.2易位/TFE3基因融合相关,伴有平滑肌基质和异常血管。
Pathol Int. 2009 Jul;59(7):486-91. doi: 10.1111/j.1440-1827.2009.02398.x.
9
The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25.人类肺泡软组织肉瘤的der(17)t(X;17)(p11;q25)将TFE3转录因子基因与位于17q25的一个新基因ASPL融合。
Oncogene. 2001 Jan 4;20(1):48-57. doi: 10.1038/sj.onc.1204074.
10
[Renal carcinoma associated with MiTF/TFE translocation: report of six cases in young adults].[与MiTF/TFE易位相关的肾癌:6例年轻成人病例报告]
Prog Urol. 2008 May;18(5):275-80. doi: 10.1016/j.purol.2008.03.026. Epub 2008 May 19.

引用本文的文献

1
A nomogram based on TFE3 IHC results and clinical factors as a preliminary screening scheme for TFE3-rearranged renal cell carcinoma.基于 TFE3 IHC 结果和临床因素的列线图作为 TFE3 重排肾细胞癌的初步筛查方案。
Cancer Med. 2024 Mar;13(5):e6813. doi: 10.1002/cam4.6813.
2
Renal cell carcinoma associated with Xp11.2 translocation/transcription factor E3 gene fusion: A case report and literature review.伴Xp11.2易位/转录因子E3基因融合的肾细胞癌:1例报告及文献复习
Oncol Lett. 2023 Nov 21;27(1):29. doi: 10.3892/ol.2023.14162. eCollection 2024 Jan.
3
The Transition From Localized to Metastatic: A Case Report of Adult TFE3-Positive Xp11.2 Translocation Renal Cell Carcinoma.
从局限性到转移性的转变:一例成人TFE3阳性Xp11.2易位性肾细胞癌病例报告
Cureus. 2023 Aug 12;15(8):e43378. doi: 10.7759/cureus.43378. eCollection 2023 Aug.
4
Xp11.2 Translocation Renal Cell Carcinoma With Rearrangement: Distinct Morphological Features and Prognosis With Different Fusion Partners.伴有重排的Xp11.2易位性肾细胞癌:不同融合伴侣的独特形态学特征及预后
Front Oncol. 2021 Nov 30;11:784993. doi: 10.3389/fonc.2021.784993. eCollection 2021.
5
Study of Treatment Outcome in Adults with TFE-Related RCC.成人TFE相关肾细胞癌治疗结果的研究。
South Asian J Cancer. 2021 Apr;10(2):92-96. doi: 10.1055/s-0041-1731264. Epub 2021 Sep 4.
6
Xp11.2 Translocation Renal Cell Carcinoma: Clinical Characteristics and Potential Prognostic Predictors.Xp11.2 易位性肾细胞癌:临床特征与潜在预后预测因子。
Dis Markers. 2021 Sep 1;2021:5647933. doi: 10.1155/2021/5647933. eCollection 2021.
7
Factors Associated with Survival From Xp11.2 Translocation Renal Cell Carcinoma Diagnosis-A Systematic Review and Pooled Analysis.与 Xp11.2 易位性肾细胞癌诊断后生存相关因素的系统评价和汇总分析。
Pathol Oncol Res. 2021 Mar 30;27:610360. doi: 10.3389/pore.2021.610360. eCollection 2021.
8
Renal cell carcinoma associated with Xp11.2 translocation/transcription factor E3 gene fusion: an adult case report and literature review.与Xp11.2易位/转录因子E3基因融合相关的肾细胞癌:1例成人病例报告及文献复习
J Int Med Res. 2020 Oct;48(10):300060520942095. doi: 10.1177/0300060520942095.
9
Characteristics and Outcome of Children with Renal Cell Carcinoma: A Narrative Review.肾细胞癌患儿的特征与转归:一项叙述性综述
Cancers (Basel). 2020 Jul 3;12(7):1776. doi: 10.3390/cancers12071776.
10
Clinicopathological Findings on 28 Cases with XP11.2 Renal Cell Carcinoma.28 例 XP11.2 肾细胞癌的临床病理观察。
Pathol Oncol Res. 2020 Oct;26(4):2123-2133. doi: 10.1007/s12253-019-00792-0. Epub 2020 Jan 18.